PortfoliosLab logoPortfoliosLab logo
IPOS vs. NVOH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IPOS vs. NVOH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Renaissance International IPO ETF (IPOS) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IPOS achieves a 40.15% return, which is significantly higher than NVOH's -13.62% return.


IPOS

1D
0.43%
1M
10.58%
YTD
40.15%
6M
44.26%
1Y
65.50%
3Y*
15.28%
5Y*
-7.69%
10Y*
3.00%

NVOH

1D
-1.79%
1M
-4.21%
YTD
-13.62%
6M
-7.70%
1Y
-37.62%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IPOS vs. NVOH - Yearly Performance Comparison


Correlation

The correlation between IPOS and NVOH is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Jan 8, 2025

0.23

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IPOS vs. NVOH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IPOS
IPOS Risk / Return Rank: 6666
Overall Rank
IPOS Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
IPOS Sortino Ratio Rank: 5858
Sortino Ratio Rank
IPOS Omega Ratio Rank: 6767
Omega Ratio Rank
IPOS Calmar Ratio Rank: 7676
Calmar Ratio Rank
IPOS Martin Ratio Rank: 6363
Martin Ratio Rank

NVOH
NVOH Risk / Return Rank: 33
Overall Rank
NVOH Sharpe Ratio Rank: 33
Sharpe Ratio Rank
NVOH Sortino Ratio Rank: 33
Sortino Ratio Rank
NVOH Omega Ratio Rank: 33
Omega Ratio Rank
NVOH Calmar Ratio Rank: 33
Calmar Ratio Rank
NVOH Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IPOS vs. NVOH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Renaissance International IPO ETF (IPOS) and Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IPOSNVOHDifference
Sharpe ratioReturn per unit of total volatility

+3.00

Sortino ratioReturn per unit of downside risk

+3.65

Omega ratioGain probability vs. loss probability

1.41

0.87

+0.54

Calmar ratioReturn relative to maximum drawdown

3.83

-0.71

+4.55

Martin ratioReturn relative to average drawdown

11.58

-1.04

+12.62

IPOS vs. NVOH - Sharpe Ratio Comparison

The current IPOS Sharpe Ratio is 2.24, which is higher than the NVOH Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of IPOS and NVOH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IPOSNVOHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.24

-0.76

+3.00

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.12

Sharpe Ratio (All Time)

Calculated using the full available price history

0.09

-0.81

+0.90

Drawdowns

IPOS vs. NVOH - Drawdown Comparison

The maximum IPOS drawdown since its inception was -73.09%, which is greater than NVOH's maximum drawdown of -61.60%. Use the drawdown chart below to compare losses from any high point for IPOS and NVOH.


Loading charts...

Drawdown Indicators


IPOSNVOHDifference

Max Drawdown

Largest peak-to-trough decline

-73.09%

-61.60%

-11.49%

Max Drawdown (1Y)

Largest decline over 1 year

-17.17%

-53.00%

+35.83%

Max Drawdown (3Y)

Largest decline over 3 years

-34.08%

Max Drawdown (5Y)

Largest decline over 5 years

-69.93%

Max Drawdown (10Y)

Largest decline over 10 years

-73.09%

Current Drawdown

Current decline from peak

-40.44%

-54.54%

+14.10%

Average Drawdown

Average peak-to-trough decline

-31.99%

-38.30%

+6.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.67%

36.09%

-30.42%

Volatility

IPOS vs. NVOH - Volatility Comparison

Renaissance International IPO ETF (IPOS) has a higher volatility of 12.05% compared to Novo Nordisk A/S (B Shares) ADRhedged ETF (NVOH) at 6.99%. This indicates that IPOS's price experiences larger fluctuations and is considered to be riskier than NVOH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IPOSNVOHDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.05%

6.99%

+5.06%

Volatility (6M)

Calculated over the trailing 6-month period

26.45%

36.21%

-9.76%

Volatility (1Y)

Calculated over the trailing 1-year period

29.41%

49.40%

-19.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.19%

49.04%

-21.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.13%

49.04%

-24.91%

IPOS vs. NVOH - Expense Ratio Comparison

IPOS has a 0.80% expense ratio, which is higher than NVOH's 0.19% expense ratio.


Dividends

IPOS vs. NVOH - Dividend Comparison

IPOS's dividend yield for the trailing twelve months is around 0.68%, less than NVOH's 3.97% yield.


PositionTTM20252024202320222021202020192018201720162015
IPOS
Renaissance International IPO ETF
0.68%1.04%0.93%0.33%0.00%0.00%0.25%0.89%1.12%0.87%1.73%1.08%
NVOH
Novo Nordisk A/S (B Shares) ADRhedged ETF
3.97%2.38%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IPOS and NVOH have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IPOS has higher volatility (12.05%) compared to NVOH (6.99%). In terms of maximum drawdown, IPOS dropped -73.09% vs NVOH's -61.60%.

On 1-year performance, IPOS leads with 65.50% vs -37.62% for NVOH. On fees, NVOH is cheaper at 0.19% per year. On volatility, NVOH has been the lower-risk option at 6.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, IPOS has performed better with a 65.50% return vs -37.62%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

NVOH is cheaper with a 0.19% expense ratio, compared with 0.80% for IPOS.

NVOH has the higher dividend yield at 3.97%, compared with 0.68% for IPOS.

They also come from different issuers: Renaissance Capital and Precidian. Their fees differ too: 0.80% for IPOS and 0.19% for NVOH.

IPOS currently has the higher Sharpe Ratio (2.24 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IPOS and NVOH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer